JP2013526582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013526582A5 JP2013526582A5 JP2013511383A JP2013511383A JP2013526582A5 JP 2013526582 A5 JP2013526582 A5 JP 2013526582A5 JP 2013511383 A JP2013511383 A JP 2013511383A JP 2013511383 A JP2013511383 A JP 2013511383A JP 2013526582 A5 JP2013526582 A5 JP 2013526582A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- cancer
- subject
- tumor antigen
- lung cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 claims 12
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 9
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 3
- 201000005202 lung cancer Diseases 0.000 claims 3
- 208000020816 lung neoplasm Diseases 0.000 claims 3
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 claims 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 2
- 102000001301 EGF receptor Human genes 0.000 claims 2
- 108060006698 EGF receptor Proteins 0.000 claims 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims 2
- 102000007066 Prostate-Specific Antigen Human genes 0.000 claims 2
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 2
- 102000013529 alpha-Fetoproteins Human genes 0.000 claims 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims 2
- 102000015736 beta 2-Microglobulin Human genes 0.000 claims 2
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 2
- 102000010792 Chromogranin A Human genes 0.000 claims 1
- 108010038447 Chromogranin A Proteins 0.000 claims 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 1
- 230000005867 T cell response Effects 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 108091008039 hormone receptors Proteins 0.000 claims 1
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34733610P | 2010-05-21 | 2010-05-21 | |
| US61/347,336 | 2010-05-21 | ||
| PCT/US2011/037327 WO2011146828A2 (en) | 2010-05-21 | 2011-05-20 | Cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013526582A JP2013526582A (ja) | 2013-06-24 |
| JP2013526582A5 true JP2013526582A5 (enExample) | 2014-07-24 |
Family
ID=44972662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511383A Pending JP2013526582A (ja) | 2010-05-21 | 2011-05-20 | 癌治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110287057A1 (enExample) |
| EP (1) | EP2571522A4 (enExample) |
| JP (1) | JP2013526582A (enExample) |
| KR (1) | KR20130113953A (enExample) |
| CN (1) | CN102883746A (enExample) |
| AU (1) | AU2011255463A1 (enExample) |
| CA (1) | CA2837059A1 (enExample) |
| IL (1) | IL222958A0 (enExample) |
| WO (1) | WO2011146828A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8475785B2 (en) | 2008-03-03 | 2013-07-02 | The University Of Miami | Allogeneic cancer cell-based immunotherapy |
| US8968720B2 (en) | 2008-03-20 | 2015-03-03 | University Of Miami | Heat shock protein GP96 vaccination and methods of using same |
| CN102223894A (zh) * | 2008-11-21 | 2011-10-19 | 迈阿密大学 | 用于产生粘膜和系统免疫的hiv/siv疫苗 |
| CN103372209B (zh) * | 2012-04-24 | 2014-09-17 | 中国科学院微生物研究所 | gp96蛋白的抗体在制备癌细胞抑制剂中的应用 |
| CN104415335A (zh) * | 2013-09-02 | 2015-03-18 | 北京中康万达医药科技有限公司 | 体内个体化系统免疫治疗方法和装置 |
| SG11201705844SA (en) * | 2015-02-06 | 2017-08-30 | Heat Biologics Inc | Vector co-expressing vaccine and costimulatory molecules |
| IL293135A (en) | 2015-05-13 | 2022-07-01 | Agenus Inc | Composition comprising at least two different complexes of a purified stress protein bound to an antigenic peptide |
| US11666649B2 (en) | 2016-10-11 | 2023-06-06 | University Of Miami | Vectors and vaccine cells for immunity against Zika virus |
| CA3058938A1 (en) | 2017-04-04 | 2018-10-11 | Heat Biologics, Inc. | Intratumoral vaccination |
| EP3720450A4 (en) * | 2017-12-04 | 2021-07-28 | Heat Biologics, Inc. | CELL-BASED VACCINE PRODUCTION |
| JP2021522239A (ja) | 2018-04-26 | 2021-08-30 | アジェナス インコーポレイテッド | 熱ショックタンパク質結合ペプチド組成物およびその使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020006413A1 (en) * | 2000-01-27 | 2002-01-17 | Sobol Robert E. | Genetically engineered tumor cell vaccines |
| EP1667701A4 (en) * | 2003-09-26 | 2007-02-14 | Univ Miami | TUMOR VACCINE |
| US8475785B2 (en) * | 2008-03-03 | 2013-07-02 | The University Of Miami | Allogeneic cancer cell-based immunotherapy |
| AU2010205782A1 (en) * | 2009-01-16 | 2011-09-08 | Agirx Limited | Vaccine compositions |
-
2011
- 2011-05-20 CA CA2837059A patent/CA2837059A1/en not_active Abandoned
- 2011-05-20 EP EP11784317.7A patent/EP2571522A4/en not_active Withdrawn
- 2011-05-20 KR KR1020127033163A patent/KR20130113953A/ko not_active Withdrawn
- 2011-05-20 US US13/112,341 patent/US20110287057A1/en not_active Abandoned
- 2011-05-20 WO PCT/US2011/037327 patent/WO2011146828A2/en not_active Ceased
- 2011-05-20 CN CN2011800232164A patent/CN102883746A/zh active Pending
- 2011-05-20 JP JP2013511383A patent/JP2013526582A/ja active Pending
- 2011-05-20 AU AU2011255463A patent/AU2011255463A1/en not_active Abandoned
-
2012
- 2012-11-11 IL IL222958A patent/IL222958A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013526582A5 (enExample) | ||
| Jiang et al. | Adoptive CD8+ T cell therapy against cancer: Challenges and opportunities | |
| Fratta et al. | The biology of cancer testis antigens: putative function, regulation and therapeutic potential | |
| CY1119941T1 (el) | Σταθερα και διαλυτα αντισωματα | |
| WO2009014708A3 (en) | Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof | |
| HK1250918A1 (zh) | 用於胶质母细胞瘤的egfr导向的car疗法 | |
| WO2011149909A3 (en) | Class i mhc phosphopeptides for cancer immunotherapy and diagnosis | |
| WO2009114085A3 (en) | Allogeneic cancer cell-based immunotherapy | |
| Öztorun et al. | The outcome of becoming a pediatric burn center in Turkey | |
| HK1201175A1 (en) | Antigen presenting cancer vaccine with gamma interferon | |
| BR112014017819A8 (pt) | Método de produzir células cancerígenas imunogênicas isoladas, células cancerígenas imunogênicas isoladas, composição imunogênica e vacina autóloga de câncer | |
| WO2009114816A3 (en) | Therapeutic cancer antigens | |
| MX2022007779A (es) | Tratamiento que involucra celulas efectoras inmunitarias modificadas geneticamente para expresar receptores de antigenos. | |
| WO2011011453A3 (en) | Phenotyping tumor-infiltrating leukocytes | |
| CN201886403U (zh) | 笔记本电脑散热装置 | |
| Vatankulu et al. | Does metastatic lymph node SUVmax predict survival in patients with esophageal cancer? | |
| CN201342031Y (zh) | 理疗用太空舱 | |
| Leung | Immunotherapy in acute leukemia | |
| Yang et al. | LBA57 MHC-II antigen presentation pathway as a predictive biomarker for sintilimab plus chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC) | |
| CN202049418U (zh) | 一种带支架笔记本电脑 | |
| Villarreal et al. | 192: IL-33 amplifies memory CD8 T cells and enhances antigen-specific tumor and viral immunity | |
| Uhde et al. | Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma | |
| Macagno et al. | Perforin-dependent Immune surveillance of ErbB2+ carcinomas in female and male mice | |
| 馬維力 et al. | Beta-Human Chorionic Gonadotropin Secreting Germinoma Refractory to Multi-Modality Treatment | |
| Öztorun et al. | Türkiye’de Çocuk Yanık Merkezi Olmanın Sonuçları |